NQO1-induced activation of AMPK contributes to cancer cell death by oxygen-glucose deprivation

Sci Rep. 2015 Jan 14:5:7769. doi: 10.1038/srep07769.

Abstract

Oxygen and glucose deprivation (OGD) due to insufficient blood circulation can decrease cancer cell survival and proliferation in solid tumors. OGD increases the intracellular [AMP]/[ATP] ratio, thereby activating the AMPK. In this study, we have investigated the involvement of NQO1 in OGD-mediated AMPK activation and cancer cell death. We found that OGD activates AMPK in an NQO1-dependent manner, suppressing the mTOR/S6K/4E-BP1 pathway, which is known to control cell survival. Thus, the depletion of NQO1 prevents AMPK-induced cancer cell death in OGD. When we blocked OGD-induced Ca(2+)/CaMKII signaling, the NQO1-induced activation of AMPK was attenuated. In addition, when we blocked the RyR signaling, the accumulation of intracellular Ca(2+) and subsequent activation of CaMKII/AMPK signaling was decreased in NQO1-expressing cells under OGD. Finally, siRNA-mediated knockdown of CD38 abrogated the OGD-induced activation of Ca(2+)/CaMKII/AMPK signaling. Taken together, we conclude that NQO1 plays a key role in the AMPK-induced cancer cell death in OGD through the CD38/cADPR/RyR/Ca(2+)/CaMKII signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / metabolism
  • AMP-Activated Protein Kinases / metabolism*
  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Signaling / drug effects
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Cyclic ADP-Ribose / metabolism
  • Enzyme Activation / drug effects
  • Glucose / deficiency*
  • Humans
  • Mice
  • Models, Biological
  • NAD / metabolism
  • NAD(P)H Dehydrogenase (Quinone) / metabolism*
  • Neoplasms / enzymology*
  • Neoplasms / pathology*
  • Oxygen / metabolism*
  • Phosphorylation / drug effects
  • RNA, Small Interfering / metabolism

Substances

  • Calcium Channel Blockers
  • RNA, Small Interfering
  • NAD
  • Cyclic ADP-Ribose
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • AMP-Activated Protein Kinases
  • ADP-ribosyl Cyclase 1
  • Glucose
  • Oxygen
  • Calcium